Cooper Research and Development Expenses 2010-2024 | COO

Cooper research and development expenses for the twelve months ending July 31, 2024 were $0.154B, a 18.72% increase year-over-year.

  • Cooper annual research and development expenses for 2023 were $0.137B, a 24.57% increase from 2022.
  • Cooper annual research and development expenses for 2022 were $0.11B, a 18.99% increase from 2021.
  • Cooper annual research and development expenses for 2021 were $0.093B, a 0.64% decline from 2020.

Cooper Research and Development Expenses 2010-2024 | COO

  • Cooper annual research and development expenses for 2023 were $0.137B, a 24.57% increase from 2022.
  • Cooper annual research and development expenses for 2022 were $0.11B, a 18.99% increase from 2021.
  • Cooper annual research and development expenses for 2021 were $0.093B, a 0.64% decline from 2020.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$78.2B
Becton Dickinson (BDX)$64.4B
Cardinal Health (CAH)$28.6B
West Pharmaceutical Services (WST)$22B
Labcorp (LH)$19.8B
Align Technology (ALGN)$16.6B
Henry Schein (HSIC)$9.3B
Merit Medical Systems (MMSI)$6.1B
DENTSPLY SIRONA (XRAY)$3.8B
CONMED (CNMD)$2.2B
Patterson (PDCO)$1.8B
STAAR Surgical (STAA)$1.3B
Lifevantage (LFVN)$170M
Pro-Dex (PDEX)$147M